‘‘(i) Promptly after providing the notice under 
subparagraph (A), the Secretary shall make avail-
able to the public all reports and data described in 
paragraph (2)(E) that are contained in the petition 
involved, and all other information in the petition to 
the extent that the information is relevant to a de-
termination of the safety for use of the additive. 
‘‘(ii) Such notice shall state whether any infor-
mation in the petition is not being made available to 
the public because the Secretary has made a deter-
mination that the information does not relate to the 
safety for use of the additive. Any person may peti-
tion the Secretary for a reconsideration of such a de-
termination. 
‘‘(C) In the case of genetic food additives: 
‘‘(i) The Secretary shall maintain and make 
available to the public through telecommunications a 
list of petitions that are pending under this sub-
section and a list of petitions for which regulations 
under subsection (c)(1)(A) have been established. 
Such list shall include information on the additives 
involved, including the source of the additives, and 
including any information received by the Secretary 
pursuant to clause (ii). 
VerDate Mar 15 2010 
23:25 Dec 05, 2011
Jkt 019200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H3554.IH
H3554
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(ii) If a regulation is in effect under sub-
section (c)(1)(A) for a genetic food additive, any 
person who manufactures such additive for commer-
cial use shall submit to the Secretary a notification 
of any knowledge of data that relate to the adverse 
health effects of the additive, when knowledge is ac-
quired by the person after the date on which the 
regulation took effect. If the manufacturer is in pos-
session of the data, the notification shall include the 
data. The Secretary shall by regulation establish the 
scope of the responsibilities of manufacturers under 
this clause, including such limits on the responsibil-
ities as the Secretary determines to be appropriate.’’. 
(3) EFFECTIVE DATE OF REGULATION REGARD-
ING
SAFE
USE; OPPORTUNITY
FOR
PUBLIC
COM-
MENT.—Section 409(c)(2) of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 348(c)(2)) is 
amended— 
(A) by striking ‘‘(2)’’ and inserting 
‘‘(2)(A)’’; and 
(B) by adding at the end the following sub-
paragraph: 
‘‘(B)(i) In the case of a genetic food additive, an 
order under paragraph (1)(A) may not be issued regarding 
the petition involved before the expiration of the applicable 
VerDate Mar 15 2010 
23:25 Dec 05, 2011
Jkt 019200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H3554.IH
H3554
mstockstill on DSK4VPTVN1PROD with BILLS
period under clause (ii). During such period, and con-
tinuing until an order under paragraph (1) is issued, the 
Secretary shall provide interested persons an opportunity 
to submit to the Secretary comments on the petition. In 
publishing such notice, the Secretary shall inform the pub-
lic of such opportunity. 
‘‘(ii) For purposes of clause (i), the applicable period 
under this clause regarding a petition is the 30-day period 
beginning on the date on which the Secretary has under 
subparagraph (B)(i) of subsection (b)(5) made informa-
tion available to the public regarding the petition, except 
that, if under subparagraph (B)(ii) of such subsection the 
Secretary finds in favor of a person who files for reconsid-
eration (relating to a determination by the Secretary that 
information does not relate to safety), such 30-day period 
is extended by an additional period of 30-days. For pur-
poses of the preceding sentence, a discrete 30-day exten-
sion applies to each such reconsideration for which the 
Secretary finds in favor of the person filing for reconsider-
ation.’’. 
(4) CONSIDERATION OF CERTAIN FACTORS.— 
Section 409(c) of the Federal Food, Drug, and Cos-
metic Act (21 U.S.C. 348(c)) is amended by adding 
at the end the following paragraph: 
VerDate Mar 15 2010 
23:25 Dec 05, 2011
Jkt 019200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H3554.IH
H3554
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(6) In the case of a genetic food additive, the factors 
considered by the Secretary regarding safety for use shall 
include (but not be limited to) the results of the following 
analyses: 
‘‘(A) Allergenicity effects resulting from the 
added proteins, including proteins not found in the 
food supply. 
‘‘(B) Pleiotropic effects. The Secretary shall re-
quire tests to determine the potential for such ef-
fects (using molecular characterization, biochemical 
characterization, mRNA profiling, or other tech-
niques, or as appropriate, combinations of such tech-
niques). 
‘‘(C) Appearance of new toxins or increased lev-
els of existing toxins. 
‘‘(D) Changes in the functional characteristics 
of food. 
‘‘(E) Changes in the levels of important nutri-
ents. 
‘‘(F) Changes in the levels of anti-nutrients.’’. 
(5) CERTAIN
TESTS.—Section 409(c) of the 
Federal Food, Drug, and Cosmetic Act, as amended 
by paragraph (4), is amended by adding at the end 
the following paragraph: 
‘‘(7) In the case of genetic food additives: 
VerDate Mar 15 2010 
23:25 Dec 05, 2011
Jkt 019200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H3554.IH
H3554
mstockstill on DSK4VPTVN1PROD with BILLS